EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Opioid biomarkers in urine as reliable and valid correlates of opium use characteristics: A 10-year longitudinal assessment

Mahdokht Naghash, Rebecca L Shaner, Hossein Poustchi, Gholamreza Roshandel, Katrice D Williams, Abraham Tuachi, Farin Kamangar, Paolo Boffetta, Christian C Abnet, Elizabeth I Hamelin, Neal D Freedman, Reza Malekzadeh und 1 weitere

Drug and Alcohol Dependence Reports · 2025-12 · 17 · 100377

DOI: 10.1016/j.dadr.2025.100377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Dependence Reports, 2025-12. Verfasst von Mahdokht Naghash und 12 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute Division of Cancer Epidemiology and Genetics, Golestan University of Medical Sciences, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biomarkers can clarify the mechanistic bases of health effects associated with opiate use and improve evaluating dose-response relationships by quantifying the absorbed dose through different routes and patterns of use, supporting the generalizability of opium research findings to broader opioid use.

Methods

We recruited 449 individuals who used opium and 66 individuals who did not, 10 years after baseline evaluation in a cohort study. At both time points, we collected self-reported characteristics of opium use (route, frequency, type, and dose) and measured urinary concentrations of codeine, hydrocodone, hydromorphone, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in spot urine samples. We used multivariate linear regression models to determine the independent effects of each opium use characteristic on biomarker concentrations. Reliability of biomarker concentrations over the 10-year interval was assessed using intraclass correlation coefficients (ICCs) from linear mixed-effect models.

Results

At the follow-up, 229 (51.0 %) subjects used opium by ingestion, which showed a significant shift compared with baseline (24.4 % ingestion). In adjusted models, opium ingestion, daily use, and presence of opioid use disorder (OUD) were associated with higher concentrations of all opioid biomarkers compared with opium smoking, non-daily use, and absence of OUD, respectively. All opioid biomarkers showed significant dose-response relationships relative to self-reported doses. Biomarker concentrations peaked when opium was used 3-4 h before sample collection and declined afterwards, remaining detectable for several days. Biomarker measurements were reliable (ICCs between 0.69 and 0.78) over the 10-year interval.

Conclusions

Opioid biomarkers are valid markers of lifetime history, route, frequency, dose, and recency of opium use and OUD diagnosis, and demonstrate good long-term reliability.

Schlagwörter

Stichwörter der Autor:innen

Opioid biomarkersOpioid use disorderOpiumSelf-reports

Autor:innen und Institutionen

  • Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Emergency Response Branch, Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Liver and Pancreaticobiliary Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
  • Battelle Memorial Institute at the Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Department of Biology, School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, MD, United States.

Förderung

  • National Cancer Institute Division of Cancer Epidemiology and Genetics
  • Golestan University of Medical Sciences
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Naghash, M., Shaner, R. L., Poustchi, H., Roshandel, G., Williams, K. D., Tuachi, A., Kamangar, F., Boffetta, P., Abnet, C. C., Hamelin, E. I., Freedman, N. D., Malekzadeh, R., & Etemadi, A. (2025). Opioid biomarkers in urine as reliable and valid correlates of opium use characteristics: A 10-year longitudinal assessment. Drug and Alcohol Dependence Reports, 17, 100377. https://doi.org/10.1016/j.dadr.2025.100377

Vancouver

Naghash M, Shaner RL, Poustchi H, Roshandel G, Williams KD, Tuachi A, et al. Opioid biomarkers in urine as reliable and valid correlates of opium use characteristics: A 10-year longitudinal assessment. Drug and Alcohol Dependence Reports. 2025;17:100377. doi:10.1016/j.dadr.2025.100377

BibTeX
@article{Naghash2025,
  author = {Naghash, Mahdokht and Shaner, Rebecca L and Poustchi, Hossein and Roshandel, Gholamreza and Williams, Katrice D and Tuachi, Abraham and Kamangar, Farin and Boffetta, Paolo and Abnet, Christian C and Hamelin, Elizabeth I and Freedman, Neal D and Malekzadeh, Reza and Etemadi, Arash},
  title = {Opioid biomarkers in urine as reliable and valid correlates of opium use characteristics: A 10-year longitudinal assessment},
  journal = {Drug and Alcohol Dependence Reports},
  year = {2025},
  volume = {17},
  pages = {100377},
  doi = {10.1016/j.dadr.2025.100377}
}
Kostenlos starten →